RANDOMIZED DOUBLE-BLIND CLINICAL TRIAL TO MEASURE THE EFFICACY OF ACTAEA RACEMOSA (9CH) AND CAULOPHYLLUM THALICTROIDES (9CH) IN THE FIRST STAGE OF LABOR

BOIRONSIH0 个研究点目标入组 114 人开始时间: 2015年7月10日最近更新: 2019年12月10日

试验速览

暂无简介。

•1. Women above 18 years old.
•2. Pregnant women between 32 and 33 weeks gestation. The calculation of gestational age was performed using the date of the last rule corrected estimated by ultrasound parameters of the first ultrasound age. If the estimated age by ultrasound exceeds 7 days estimated by last menstrual period, it will assume the sonographically estimated as correct.
•3. Carrier single fetus in cephalic presentation at the time of recruitment.
•4. Compliance of pregnant women to participate in this study by signing the informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 114
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1. Women who have undergone cesarean in a previous pregnancy.
•2. Women who are being treated with medications for chronic disease.
•3. Women who have had gestational diabetes during this pregnancy (diabetes, hypertension, urinary tract infection present, severe anemia) and / or present a pregnancy of moderate / high risk.
•4. Presence of fetal pathology (malformations, intrauterine growth retardation, etc.)
•5. Presence of placental abnormalities (single umbilical artery, placental insufficiency, placenta previa, etc.)
•6. Presence of current or resolved in less than 15 days time fetal or maternal infection.
•7. Bleeding disorder mother of the third quarter.
•8. Women with severe mental illness.
•9. Women who have decided to give birth by elective Caesarean section.
•10. Women who suffer from lactose intolerance.
•11. Women whose condition does not make them eligible for the study, according to the researcher.

发起方

BOIRONSIH